Penile Implants
Penile prosthesis implantation is the definitive surgical treatment for erectile dysfunction (ED) refractory to medical management or when other treatments are contraindicated or unacceptable. With patient satisfaction rates consistently exceeding 90%, it represents the highest-satisfaction intervention in sexual medicine. The procedure irreversibly alters corporal tissue and eliminates natural erections — a critical informed consent point — but does not affect urination, ejaculation, penile sensation, or orgasm.
This page gives the high-level overview. For a deeper treatment of specific topics, see the subsection articles:
- Preoperative EvaluationPatient selection (CURSED framework), medical optimization (HbA1c, MRSA decolonization, smoking, anticoagulation), physical exam specifics, informed consent essentials unique to IPP, and special-population planning (post-prostatectomy, Peyronie's, prior explantation, post-radiation, neophallus).
- Intraoperative SetupAnesthesia options, dorsal penile block technique, positioning, ChloraPrep skin antisepsis, the Eid no-touch adhesive-barrier protocol, modern antibiotic regimen, device preparation (dip vs. do-not-dip), instrument set, and closure/hand-off pathway.
- Surgical ApproachesPenoscrotal (PS), infrapubic (IP), subcoronal (SC), and transverse scrotal (TS) — side-by-side trade-offs, step-by-step technique for each, and a first-50-cases adoption sequence for the new prosthetic urologist.
- Reservoir PlacementSpace of Retzius (classic), high submuscular (HSM) ectopic, and the 2-piece alternative. Arcuate line anatomy, decision framework by altered anatomy (prostatectomy, cystectomy, transplant, hernia mesh, radiation), fill volumes, and reservoir-specific complications (autoinflation, herniation, bladder/bowel injury).
- Implant ModelsAt-a-glance database of 2026 clinical-use devices — AMS 700 CX/LGX/CXR, Coloplast Titan OTR/Touch/Zero Degree, Rigicon Infla10, Ambicor, Tactra, Genesis, Spectra, Rigi10, Promedon Tube, ZSI 475/100 — with coating handling, sizing, and selection framework by patient type.
- Infection — Evolution, Evidence, and Modern ControversiesHow IPP infection rates fell from 8–15% to ~1%, the microbial landscape shift (MRSA / gram-negative / fungal), the AUA guideline controversy, antifungal prophylaxis as the strongest modifiable signal, and device-specific Irrisept use. 29 citations.
- Revision ScenariosCorporal fibrosis and the cavernotome toolkit (Mooreville, Ghanem, Uramix), crural crossover, corporal perforation, residual curved erection, SST (supersonic transit) deformity, pump and reservoir complications, and the modified-Mulcahy salvage washout protocol.
- Complications (Non-Infectious)Erosion (cylinder through glans/urethra, pump, reservoir-into-bladder), glans ischemia and necrosis, cylinder aneurysm, mechanical failure, urinary retention, hematoma, chronic pain, and sensory changes — rates, mechanisms, management, and the counseling framework.
Indications
Penile implants are indicated for men with moderate-to-severe ED who have failed or cannot use less invasive treatments (PDE5 inhibitors, VED, ICI), or who prefer a permanent solution. Expanded indications include:
- Organic ED refractory to PDE5 inhibitors, VED, and intracavernosal injection therapy
- Peyronie's disease with concurrent ED
- Corporal fibrosis from priapism, infection, or prior surgery
- Post-prostatectomy or radiation-induced ED with failed medical management
- Prior prosthesis explantation requiring replacement
- Neophallus construction (phalloplasty in gender-affirming surgery)
- Refractory ischemic priapism (as definitive treatment)
Contraindications: Active infection (local or systemic), inadequate medical optimization, unrealistic patient expectations, or significant psychiatric comorbidity.
Preoperative Assessment
Medical Optimization
Risk factors for infection and device failure should be optimized before surgery:
| Factor | Target |
|---|---|
| Diabetes | HbA1c <8.5% (ideally <7%) |
| Obesity | BMI <30 |
| Active UTI | Treat and clear before proceeding |
| Immunosuppression | Optimize where possible |
| Testosterone | Correct hypogonadism if present |
Psychological Screening — "CURSED" Traits
The CURSED mnemonic identifies patients at elevated risk for post-implant dissatisfaction:
| Letter | Trait |
|---|---|
| C | Compulsive personality |
| U | Unrealistic expectations |
| R | Revision — previously operated elsewhere |
| S | Surgeon shopping |
| E | Entitled / demanding |
| D | Denial / Psychiatric disorder |
Informed Consent Essentials
Patients must understand:
- Natural erections will no longer be possible after implantation
- The procedure is considered permanent and irreversible
- Approximately 50% lifetime mechanical revision rate (10+ years)
- High satisfaction despite revision burden (>90% would repeat the procedure)
- Risk of infection, erosion, and device failure requiring explantation
Device Types
Three-Piece Inflatable Penile Prosthesis (3-piece IPP)
The gold standard in most health systems. Consists of:
- Two intracavernosal cylinders providing rigidity and expansion
- Intrascrotal pump with valve mechanism for inflation/deflation
- Retropubic fluid reservoir (typically 65–100 mL capacity) placed in the space of Retzius or ectopically
Advantages: Best flaccidity and erect rigidity; most natural appearance and function; highest patient satisfaction among device types.
Disadvantages: Most mechanically complex; requires reservoir placement; demands adequate manual dexterity; longer operative time.
Two-Piece Inflatable Penile Prosthesis (2-piece IPP)
Self-contained system integrating the reservoir into the pump mechanism. No separate abdominal reservoir required.
Advantages: Avoids reservoir placement (relevant in prior pelvic surgery, transplant recipients); simpler implantation; good option for standard anatomy.
Disadvantages: Less rigidity and less complete flaccidity than 3-piece; limited cylinder expansion.
Malleable / Semi-Rigid Prosthesis
Two firm, bendable rods implanted into the corpora cavernosa. Device is manipulated (bent down to conceal, bent upward to use).
Advantages: Simplest implantation and operation; most durable (no fluid components to fail); suitable for limited dexterity; good length conservation.
Disadvantages: Permanent semi-erect state that can be difficult to conceal; less natural appearance; lower satisfaction scores than inflatable devices.
Device Model Comparison
Three-Piece Inflatable Prostheses
| Model | Manufacturer | Cylinder Type | Key Features |
|---|---|---|---|
| AMS 700 CX | Boston Scientific | Controlled expansion (girth only) | Workhorse 3-piece; InhibiZone antibiotic coating; Momentary Squeeze (MS) pump variant |
| AMS 700 LGX | Boston Scientific | Length + girth expansion | Only cylinder with longitudinal expansion; good for shorter penises |
| AMS 700 CXR | Boston Scientific | Narrow-base controlled expansion | Narrow cuff for smaller corpora; revision and fibrosis cases |
| Titan OTR | Coloplast | Girth expansion | Hydrophilic coating (absorbs antibiotic solution at implant); One-Touch Release deflation |
| Titan Touch | Coloplast | Girth expansion | Tactile ridges on pump for easier identification; hydrophilic coating |
| Turo 3-Piece | Rigicon | Girth expansion | Newer entrant; antibiotic-impregnated coating; competitive cylinder sizing range |
Two-Piece Inflatable Prostheses
| Model | Manufacturer | Notes |
|---|---|---|
| AMS Ambicor | Boston Scientific | Reservoir integrated into rear-tip of cylinders; simple pump; good for prior pelvic surgery or transplant patients |
| Infla10 2-Piece | Rigicon | Newer platform; fluid reservoir within pump housing; alternative to Ambicor |
Malleable / Semi-Rigid Prostheses
| Model | Manufacturer | Notes |
|---|---|---|
| AMS 650 | Boston Scientific | Silver-wound wire core; soft silicone jacket; standard malleable |
| Genesis | Coloplast | Polytetrafluoroethylene coating; tactile position indicator; memory-flex core |
| Acu-Form | Rigicon | Dual-layer silicone; malleable silver core |
| Tube | Promedon | Hydraulic malleable hybrid; internal fluid transfer for improved rigidity on demand |
Coating Technologies
| Technology | Manufacturer | Mechanism |
|---|---|---|
| InhibiZone™ | Boston Scientific | Silicone impregnated with rifampin + minocycline; releases antibiotics locally for ~72 hours |
| Hydrophilic Coating | Coloplast (Titan) | Absorbs antibiotic solution intraoperatively (e.g., gentamicin + vancomycin); surgeon-customizable antibiotic choice |
| Parylene Microcoating | Multiple | Ultra-thin polymer barrier reducing protein adhesion and biofilm formation |
Surgical Technique
Approaches
| Approach | Incision | Best For | Notes |
|---|---|---|---|
| Penoscrotal (PS) | Transverse at penoscrotal junction | Primary implants; most common | Direct pump placement; excellent corporal access; slightly longer activation wait |
| Infrapubic (IP) | Lower abdominal above pubic bone | Surgeon preference; earlier activation | Direct reservoir visualization; higher dorsal nerve injury risk; faster operative time |
| Subcoronal (SC) | Circumcising / degloving incision | Complex reconstructive cases | Full corporal access for fibrosis, Peyronie's correction, concurrent work |
Key Operative Steps
- Corporotomy — longitudinal incision into corpora cavernosa bilaterally
- Corporal dilation — sequential dilation to measured length; cavernotomes for fibrosis
- Sizing — measure corporal length; select cylinder ± rear-tip extenders to fill space
- Cylinder placement — cylinders deployed with Keith needle; proximal cap to crus, distal tip to glans
- Reservoir placement (3-piece) — space of Retzius via created defect in transversalis fascia; ectopic subfascial if prior pelvic surgery
- Pump placement — dependent scrotal position between dartos layers; bilateral testicular placement avoidance
- Connection and cycle test — tubing connected, device inflated/deflated to confirm function before closure
- Closure — layered; device left partially inflated in many protocols
"No-touch" technique: Device handled only with instrument tips, not hands, to minimize contamination. Wound irrigation with antibiotic/antifungal solution before closure. No suction drains (increase infection risk).
Operative Time
Approximately 70–95 minutes for primary cases; infrapubic approaches are generally faster than penoscrotal.
Complications
Early (within 2 weeks)
| Complication | Rate |
|---|---|
| Overall early complications | ~4.6% |
| Hematoma | ~0.6% |
| Urinary retention | ~5.8% |
| Early infection | ~0.4% |
| Early revision | ~0.5% |
Late
| Complication | Rate | Notes |
|---|---|---|
| Infection | 1–3% (primary); up to 10%+ (revision/radiation) | Most feared; often requires complete explantation |
| Mechanical failure | ~15% at 5–11 years | Fluid leak, tubing kink, pump/cylinder failure; improved with modern devices |
| Erosion | 0.02–5% (up to 32.5% in high-risk) | Cylinder through urethra or glans; pump/reservoir through skin |
| Urethral injury | Uncommon intraoperatively | Abort procedure; repair and delay reimplantation |
| Penile shortening | Variable | Preoperative counseling essential; Peyronie's patients at highest risk |
| Glans ischemia | Rare | Distal cylinder oversizing; crossover injury |
| Sensory change | Variable | Infrapubic approach carries slightly higher dorsal nerve risk |
Infection Management
Infection typically mandates complete device explantation. The salvage protocol (Mulcahy technique) — immediate device replacement with antibiotic wound irrigation — can be attempted in select cases without tissue erosion, with salvage rates of ~80–90% in experienced hands.
Outcomes
Functional Success and Satisfaction
| Metric | Rate |
|---|---|
| Overall functional success | >90% |
| Prosthesis functional at 2–3 years | 88–94% |
| Patient satisfaction | 70–90% (up to 92–98% in prospective series) |
| Partner satisfaction | Up to 90% |
| Would repeat the procedure | >90% |
Predictors of Satisfaction
- Surgeon experience is the only independent predictor of higher satisfaction; improvement plateaus at ~15 procedures/year
- Hydraulic devices report higher satisfaction scores than malleable prostheses
- Absence of complications correlates strongly with satisfaction
- Middle-aged men may report lower satisfaction than younger and older patients
- Comprehensive preoperative counseling and realistic expectation-setting improves outcomes
Long-Term Durability
- Mechanical revision-free survival: ~80% at 5 years; ~50% at 10+ years
- Modern coating technologies and device redesign have progressively reduced failure rates
- Functional life expectancy: 10–15 years for contemporary devices
Special Populations
Peyronie's disease with ED: IPP implantation straightens most curvatures mechanically; severe residual curvature requires concurrent modeling (gentle manual bending), plication, or grafting at time of implant.
Corporal fibrosis (priapism, prior infection, revision): Specialized dilation tools (cavernotomes, Rossello dilators, Carter-Trost technique) create space in scarred corpora. Malleable implants may be preferred when fibrosis is severe.
Post-radiation: Higher infection and erosion risk; antibiotic coating and meticulous technique critical; patients counseled on reduced durability.
Neophallus (phalloplasty patients): No native corpora; implant placed in surgically created neocorpora or directly in the neophallus tissue. Technically demanding; malleable or narrow-profile devices preferred. Erosion rates higher than in cis men.
Concurrent penile prosthesis + AUS: Staged or simultaneous implantation safely performed in experienced centers; pump positioning planned to avoid device-on-device conflict in the scrotum.
Postoperative Management
- Immediate: Partial device inflation for 24 hours to 2 weeks to reduce hematoma and promote tissue molding around cylinders
- Activation visit: At 4–6 weeks — wound assessment, pump cycling instruction, patient education on device use
- Pain management: Multimodal protocols (nerve block, NSAIDs, non-narcotic analgesics); narcotic-free pathways increasingly adopted
- Sexual activity: Typically cleared at the activation visit (~4–6 weeks)
- Device ID card: Patients carry identification for TSA screening and MRI clearance purposes
Counseling Summary
| Point | Detail |
|---|---|
| Natural erections after surgery | Not possible — irreversible change |
| Patient satisfaction | >90% across major series |
| Mechanical revision at 10 years | ~50% |
| Infection risk | 1–3% primary; higher with radiation/revision |
| Effect on sensation / orgasm | None — preserved |
| Effect on ejaculation | None — preserved |
| Sexual activity clearance | ~4–6 weeks postoperatively |
References
- Levine LA, Becher EF, Bella AJ, et al. Penile prosthesis surgery: current recommendations from the International Consultation on Sexual Medicine. J Sex Med. 2016;13(4):489–518. PMID 26944463
- Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381(9861):153–65. PMID 23040455
- Goodstein T, Jenkins LC. A narrative review on malleable and inflatable penile implants: choosing the right implant for the right patient. Int J Impot Res. 2023;35(7):623–28. PMID 37308564
- Giordano A, Smarrazzo F, Cilio S, et al. History of penile implants: from implants made of bone to modern inflatable penile implants. Int J Impot Res. 2023;35(7):601–08. PMID 37308550
- Barnard JT, Cakir OO, Ralph D, Yafi FA. Technological advances in penile implant surgery. J Sex Med. 2021;18(7):1158–66. PMID 34052144
- Otero JR, Manfredi C, Wilson SK. The good, the bad, and the ugly about surgical approaches for inflatable penile prosthesis implantation. Int J Impot Res. 2022;34(2):128–37. PMID 33199835
- Perito P, Mulcahy J, Wen L, Wilson SK. Nuances of infrapubic incision for inflatable penile prosthesis. Int J Impot Res. 2022;34(6):524–33. PMID 33859355
- Weinberg AC, Pagano MJ, Deibert CM, Valenzuela RJ. Sub-coronal inflatable penile prosthesis placement with modified no-touch technique. J Sex Med. 2016;13(2):270–6. PMID 26762974
- Moukhtar Hammad MA, Barham DW, Sanford DI, et al. Maximizing outcomes in penile prosthetic surgery. Int J Impot Res. 2023;35(7):613–19. PMID 37308559
- Cocci A, Capogrosso P, Minhas S, et al. Penile prosthesis implantation: a systematic review of intraoperative and postoperative complications. Int J Impot Res. 2025. doi:10.1038/s41443-025-01108-4
- Van Renterghem K, De Bruyn H, Yebes A, et al. Early complications after penile prosthesis surgery: findings from the PHOENIX multicenter registry. Int J Impot Res. 2025. doi:10.1038/s41443-025-01080-z
- Beirnaert J, Pinar U, Benarroche D, Akakpo W, Rouprêt M. Evaluation of patient satisfaction using the validated French version of the SSIPI questionnaire after inflatable penile implantation. J Sex Med. 2023;21(1):67–71. PMID 38064491
- Altal Y, Al-Huneidy L, Karam A, et al. Patients' satisfaction rate after penile implant surgery: a cross-sectional investigation from the Middle East. Sci Rep. 2025;15(1):34410. doi:10.1038/s41598-025-17391-6
- Ralla B, Goranova I, Börnstein N, et al. Complications, functional and quality of life outcomes following primary and secondary implantation of penile prosthesis at a tertiary referral center. Int J Impot Res. 2018;30(2):49–53. PMID 29467526
- Capogrosso P, Pescatori E, Caraceni E, et al. Satisfaction rate at 1-year follow-up in patients treated with penile implants: data from the multicentre prospective registry INSIST-ED. BJU Int. 2019;123(2):360–66. PMID 30133994
- Preto M, Falcone M, Plamadeala N, et al. Risk of unfavorable outcomes after penile prosthesis implantation — results from a national registry (INSIST-ED). Int J Impot Res. 2024;36(8):842–47. PMID 37580494
- Luna E, Rodriguez D, Barrios D, et al. Evaluation of quality of life after inflatable penile implantation and analysis of factors influencing postsurgery patient satisfaction. J Sex Med. 2022;19(9):1472–78. PMID 35773196
- Ioannis M, Georgios L, Stavros T, Anastasios A, Koenraad VR. Update on penile prosthesis. Asian J Androl. 2025. doi:10.4103/aja2024100
- Ancha N, Eldin M, Woodle T, et al. Current devices, outcomes, and pain management considerations in penile implant surgery: an updated review. Asian J Androl. 2024;26(4):335–43. PMID 38386335